Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory Neuroblastoma

NCT06751134 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma, Recurrent, Refractory

Interventions

DRUG: Chimeric Natural Killer Receptor Universal T-cells (CNK-UT)

Sponsor

Nanjing Children's Hospital